Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system
Open Access
- 10 April 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (10), 1169-1170
- https://doi.org/10.1093/eurheartj/ehp135
Abstract
Prostate-specific antigen (PSA), considered only an established marker for the detection of prostate cancer, has been identified as a member (hK3) of the human kallikrein family of serine proteases and now, it is known that PSA is not specific to prostate, semen, and gender. Increased PSA serum levels have been reported also in cardiovascular patients and both elevated as well as diminished PSA have been reported during acute myocardial infarction (AMI). Preliminary observations have concluded that when elevation of prostate-specific antigen occurs during AMI, it seems to relate to a higher occurrence of major adverse cardiac events and that coronary lesions are frequent and often more severe than when a diminution of PSA occurs. Large studies need to be done to confirm these preliminary results but the journey of PSA could be longer than expected.Keywords
This publication has 33 references indexed in Scilit:
- Generation of angiostatin-like fragments from plasminogen by prostate-specific antigenBritish Journal of Cancer, 1999
- Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1International Journal of Cancer, 1999
- Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the ProstateCritical Reviews in Clinical Laboratory Sciences, 1998
- Serpin-derived Peptide Substrates for Investigating the Substrate Specificity of Human Tissue Kallikreins hK1 and hK2Published by Elsevier BV ,1997
- Nontraumatic Elevation of Prostate Specific Antigen Following Cardiac Surgery and Extracorporeal Cardiopulmonary BypassJournal of Urology, 1994
- Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient ageClinical Biochemistry, 1994
- Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*Journal of Clinical Endocrinology & Metabolism, 1991
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991
- Molecular cloning of human prostate specific antigen cDNAFEBS Letters, 1987
- Human prostate-specific antigen: structural and functional similarity with serine proteases.Proceedings of the National Academy of Sciences of the United States of America, 1986